肱骨近端骨折手术短期并发症已减少:国家手术质量改进计划数据库分析
该研究基于2007至2018年NSQIP数据库5889例肱骨近端骨折手术患者,分析手术方式趋势与30天并发症。结果发现反向全肩关节置换术(RTSA)和切开复位内固定(ORIF)使用率上升,半肩关节置换术(HA)下降,各术式轻微并发症率均随时间降低。
要点
- RTSA使用比例从2007年4%升至2018年34%,ORIF从46%升至57%,HA从50%降至9%(均p<0.001)。
- 2018年轻微并发症率:RTSA 10%、ORIF 5%、HA 6%,各术式随时间下降(p<0.001、p=0.01、p=0.01)。
- 研究后期关节置换术(RTSA和HA)与ORIF相比,30天主要或轻微并发症无独立关联。
核心结论
- RTSA使用增加及固定与关节置换术短期并发症率下降,代表肱骨近端骨折治疗相较近期历史常规的显著变化。
- 量化人口学、损伤特征和合并症与手术方式选择及并发症的关联,为决策支持工具奠定基础。
- 未来研究应探究更长期并发症率及短期并发症率下降的机制。
研究设计与样本
- 回顾性分析国家手术质量改进计划(NSQIP)数据库2007至2018年数据,使用当前操作术语及ICD-9和ICD-10编码识别肱骨近端骨折行ORIF、HA或RTSA的患者。
- 共纳入5889例17岁及以上肱骨近端骨折患者,排除孤立大结节、肱骨干、肱骨远端骨折、骨不连、畸形愈合及翻修手术者。
- 采用Cochran-Armitage检验评估手术趋势,多变量逻辑回归模型识别与手术方式和并发症相关的协变量。
- 证据等级:Level III,治疗性研究。
主要发现
- RTSA比例从2007年4%升至2018年34%(p<0.001),ORIF从46%升至57%(p<0.001),HA从50%降至9%(p<0.001)。
- 各术式轻微并发症率随时间下降:RTSA 2018年10%(p<0.001),ORIF 2018年5%(p=0.01),HA 2018年6%(p=0.01)。
- 控制糖尿病、慢性阻塞性肺疾病、充血性心力衰竭、透析及术前输血等混杂变量后,年龄较大、BMI较高、功能独立状态及吸烟与选择RTSA而非HA的 odds 增加独立相关。
- 年龄较大、BMI较高、ASA分级较高、吸烟、使用类固醇/免疫抑制剂及三部分和四部分骨折与选择ORIF而非RTSA和HA的 odds 降低独立相关。
- 控制年龄、ASA分级、功能状态及术前输血后,研究后期关节置换术(RTSA和HA)与ORIF相比,30天主要或轻微并发症无独立关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出研究无法回答围手术期之外的并发症问题。
- 原文指出未来研究应探究更长期并发症率,因为所比较方法间的许多差异可能发生在围手术期之后。
- 原文指出未来工作可能还应探究短期并发症率下降的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple surgical treatments exist for proximal humerus fractures (PHFs), but current practice patterns and short-term complication profiles remain poorly understood. This is in part due to changes in treatment paradigms over the past decade. A more thorough understanding of the evolution in management over this time as well as an appreciation of the preoperative factors associated with both the chosen surgical modality and short-term complications will help inform future surgical considerations. QUESTIONS/PURPOSES: In this study, we sought to: (1) characterize trends in the surgical management of PHFs over time, including usage rates of various surgical modalities and changes in complication rates; (2) identify preoperative variables associated with the selection of surgical modality; and (3) assess the independent covariates of acute 30-day complications, including demographic variables, injury characteristics, and treatment type. METHODS: The National Surgical Quality Improvement Program (NSQIP) database was queried using Current Procedural Terminology and ICD-9 and ICD-10 codes to identify individuals with PHF undergoing open reduction and internal fixation (ORIF), hemiarthroplasty (HA), or reverse total shoulder arthroplasty (RTSA) from 2007 to 2018. The NSQIP database was utilized because of its collection of detailed preoperative demographic information and large repository of clinically derived data, which is felt to be more accurate than claims or administrative data. In total, 5889 patients with PHFs met the inclusion criteria. Patients 17 years or older were included. Patients with isolated greater tuberosity, humeral shaft, and distal humerus fractures; nonunions; malunions; and those undergoing revision procedures were excluded. A Cochran-Armitage test was used to evaluate surgical trends over time. Multivariable logistic regression models were created to identify covariates associated with surgical modality and complications. Although complications were either classified as major or minor, specific complications were also individually analyzed to avoid potentially misleading conclusions associated with pooling. RESULTS: The proportion of patients with PHFs undergoing RTSA (4% in 2007 and 34% in 2018; p < 0.001) and ORIF (46% in 2007 and 57% in 2018; p < 0.001) increased over time, and the proportion of those undergoing HA (50% in 2007 and 9% in 2018; p < 0.001) decreased. Across each surgical modality, minor complication rates decreased over time (RTSA: 10% in 2018; p < 0.001; ORIF: 5% in 2018; p = 0.01; and HA: 6% in 2018; p = 0.01). After controlling for confounding variables like diabetes, chronic obstructive pulmonary disease, congestive heart failure, dialysis, and preoperative blood transfusion, the following factors were independently associated with an increased odds of a patient undergoing RTSA rather than HA: older age, higher BMI, independent functional status, and smoking. The following factors were independently associated with a decreased odds of a patient undergoing ORIF rather than RTSA and HA: older age, higher BMI, higher American Society of Anesthesiologists (ASA) classification, smoking, steroid/immunosuppressant use, as well as three- and four-part fractures. After controlling for age, ASA classification, functional status, and preoperative blood transfusion, we also found that in the latter part of the study period, arthroplasty (RTSA and HA) was no longer independently associated with 30-day major or minor complications compared with ORIF. CONCLUSION: The increasing utilization of RTSA and decreasing short-term complication rates for fixation and arthroplasty alike represent a substantial change compared even with recent historic norms in the management of proximal humerus fractures. Quantifying demographics, injury characteristics, and comorbidities associated with both the choice of surgical modality and complications serves as the groundwork for decision support tools, which can inform patients and surgeons of the probability of a particular surgical modality being chosen and the risk of complications, based on national benchmarks. Future studies should investigate longer term complication rates, as many differences between the approaches being compared might occur beyond the perioperative period and our study had no means to address questions about complications beyond that period, but obviously those must be considered when choosing a treatment for patients with these injuries. Future work might also investigate the mechanisms behind the decreasing rates of short-term complications. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Cognetti DJ, Arana AA, Hoof M, et al. Short-term Complications for Proximal Humerus Fracture Surgery Have Decreased: An Analysis of the National Surgical Quality Improvement Program Database. Clin Orthop Relat Res. 2022. PMID: 36111889. doi:10.1097/CORR.0000000000002391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。